Concretely speaking, KIFC1 was upregulated in ovarian cancer cells and could serve as a biomarker that predicted worse prognosis, poor overall survival, and initiation of metastatic dissemination in patients with ovarian cancer. This evidence concerns the gene KIFC1 and ovarian carcinoma.